{"product_id":"prescribing-lithium-cafers-psychopharmacology-2nd-edition-series","title":"Prescribing Lithium: Cafer's Psychopharmacology 2nd Edition Series","description":"To excel in psychopharmacology, one must master lithium. Patients with mood disorders do best when their provider manages lithium safely and effectively. Research consistently shows that appropriate use improves outcomes, reduces suicide risk, and may even prevent Alzheimer’s disease and extend healthy lifespan.\nThis is a lithium-centric pharmacology book. Outside of The Lithium Handbook by Meyer \u0026amp; Stahl (2023), reliable prescribing information remains scarce. The FDA package insert is outdated, exposing kidneys to more lithium than necessary if followed literally.\nDrug interaction tools further complicate practice, as they vastly overrepresent pharmacodynamic interactions while overlooking some pharmacokinetic ones. In this book, every purported lithium interaction from major checkers has been investigated. The Annotated Glossary serves as a comprehensive starting point for assessing whether a medication interacts.\nFor psychiatric prescribers, lithium interactions pose a unique challenge: the list of interacting drugs differs markedly from those relevant to our other treatments. Core information about these medications is included — not so you can prescribe them, but so you can understand what your patients receive from other clinicians. For example, if a patient is taking 25 mg of hydrochlorothiazide, this book shows how significant that dose is in a lithium-specific context.\nTreatment guidelines are also provided, using Osser’s Psychopharmacology Algorithms (2020) as scaffolding. Evidence-based practice leads naturally to managing a large number of lithium patients — and therefore, their lithium-related side effects. The most consequential is vasopressin resistance (nephrogenic diabetes insipidus, NDI). Competent lithium care requires proficiency with amiloride, the specific antidote. As amiloride management requires attention to medications that shift serum potassium, this book includes a secondary focus on potassium-modifying drugs.\nIn short, this book integrates lithium’s evidence base, interaction profiles, treatment guidelines, and side effect management into a unified, practical system. By combining visual mnemonics and detailed prescribing guidance, it is designed to equip clinicians with the skills needed for safe, effective, and enduring lithium care.\u003cbr\u003eASIN: 1735090182\u003cbr\u003eVSKU: BVV.1735090182.G\u003cbr\u003eCondition: Good\u003cbr\u003eAuthor\/Artist:Cafer MD, Jason\u003cbr\u003eBinding: Paperback\u003cbr\u003e\u003cb\u003eNote:\u003c\/b\u003e Any images shown are stock photographs and product may differ from what is shown.  \u003cbr\u003e\u003cb\u003eCondition Notes\u003c\/b\u003e: The item shows wear from consistent use, but it remains in good condition and works perfectly. All pages and cover are intact  including the dust cover, if applicable . Spine may show signs of wear. Pages may include limited notes and highlighting. May NOT include discs, access code or other supplemental materials.  \u003cbr\u003e","brand":"Blue Vase Books","offers":[{"title":"Default Title","offer_id":43334701613117,"sku":"BVV.1735090182.G","price":23.03,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.bluevasebooks.com\/products\/prescribing-lithium-cafers-psychopharmacology-2nd-edition-series","provider":"Blue Vase Books","version":"1.0","type":"link"}